{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:00:46Z","timestamp":1777111246328,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40360-017-0120-2","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T12:30:44Z","timestamp":1486470644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A rare case report of acyclovir-induced immune thrombocytopenia with tongue hematomas as the first sign, and a literature review"],"prefix":"10.1186","volume":"18","author":[{"given":"Xiaowei","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,7]]},"reference":[{"key":"120_CR1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/510206","volume":"44","author":"RH Dworkin","year":"2007","unstructured":"Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007;44:S1\u2013S26.","journal-title":"Clin Infect Dis"},{"key":"120_CR2","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJM199209103271108","volume":"327","author":"RJ Whitley","year":"1992","unstructured":"Whitley RJ, Gnann Jr JW. Acyclovir: a decade later. N Engl J Med. 1992;327:782\u20139.","journal-title":"N Engl J Med"},{"key":"120_CR3","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1097\/MJT.0b013e31826fc4be","volume":"21","author":"J Kamboj","year":"2014","unstructured":"Kamboj J, Wu F, Kamboj R, Suzue K, Khosla P. A rare case of acyclovir-induced thrombocytopenia. Am J Ther. 2014;21:e159\u201362.","journal-title":"Am J Ther"},{"key":"120_CR4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0190-9622(95)91344-0","volume":"32","author":"M Busso","year":"1995","unstructured":"Busso M, Berman B. Antivirals in dermatology. J Am Acad Dermatol. 1995;32:1031\u201340.","journal-title":"J Am Acad Dermatol"},{"key":"120_CR5","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/00007611-199412000-00006","volume":"87","author":"JC Adair","year":"1994","unstructured":"Adair JC, Gold M, Bond RE. Acyclovir neurotoxicity: clinical experience and review of the literature. South Med J. 1994;87:1227\u201331.","journal-title":"South Med J"},{"key":"120_CR6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0002-9343(93)90186-S","volume":"94","author":"WE Haefeli","year":"1993","unstructured":"Haefeli WE, Schoenenberger RA, Weiss P, Ritz RF. Acyclovir-induced neurotoxicity: concentration-side effect relationship in acyclovir overdose. Am J Med. 1993;94:212\u20135.","journal-title":"Am J Med"},{"key":"120_CR7","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/clinids\/20.6.1557","volume":"20","author":"HM Feder Jr","year":"1995","unstructured":"Feder Jr HM, Goyal RK, Krause PJ. Acyclovir-induced neutropenia in an infant with herpes simplex encephalitis: case report. Clin Infect Dis. 1995;20:1557\u20139.","journal-title":"Clin Infect Dis"},{"key":"120_CR8","first-page":"317","volume":"31","author":"AM Tuncer","year":"1989","unstructured":"Tuncer AM, Evis B, Kunak B, Ak\u00e7ay\u00f6z N, Ertem U. Erythroblastopenia and leukopenia in the patient with severe herpes zoster treated with intravenous acyclovir. Turk J Pediatr. 1989;31:317\u201321.","journal-title":"Turk J Pediatr"},{"key":"120_CR9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0735-6757(98)90138-3","volume":"16","author":"M Grella","year":"1998","unstructured":"Grella M, Ofosu JR, Klein BL. Prolonged oral acyclovir administration associated with neutropenia and thrombocytopenia. Am J Emerg Med. 1998;16:396\u20138.","journal-title":"Am J Emerg Med"},{"key":"120_CR10","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1592\/phco.30.10.1085","volume":"30","author":"S Katsenos","year":"2010","unstructured":"Katsenos S, Gkolias D, Nikolopoulou M. Acyclovir-induced immune thrombocytopenia in a patient with herpes zoster of the trigeminal nerve. Pharmacotherapy. 2010;30:1085.","journal-title":"Pharmacotherapy"},{"key":"120_CR11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tmrv.2013.05.005","volume":"27","author":"DM Arnold","year":"2013","unstructured":"Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, Kelton JG. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev. 2013;27:137\u201345.","journal-title":"Transfus Med Rev"},{"key":"120_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(02)39906-9","volume":"86","author":"W Vipan","year":"1865","unstructured":"Vipan W. Quinine as a cause of purpura. Lancet. 1865;86:37.","journal-title":"Lancet"},{"key":"120_CR13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra066469","volume":"357","author":"RH Aster","year":"2007","unstructured":"Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357:580\u20137.","journal-title":"N Engl J Med"},{"key":"120_CR14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1538-7836.2009.03360.x","volume":"7","author":"RH Aster","year":"2009","unstructured":"Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost. 2009;7:911\u20138.","journal-title":"J Thromb Haemost"},{"key":"120_CR15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.0954-6820.1981.tb09853.x","volume":"210","author":"LE B\u00f6ttiger","year":"1981","unstructured":"B\u00f6ttiger LE, B\u00f6ttiger B. Incidence and cause of aplastic anemia, hemolytic anemia, agranulocytosis and thrombocytopenia. Acta Med Scand. 1981;210:475\u20139.","journal-title":"Acta Med Scand"},{"key":"120_CR16","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1001\/jama.1984.03350230017024","volume":"252","author":"DA Danielson","year":"1984","unstructured":"Danielson DA, Douglas 3rd SW, Herzog P, Jick H, Porter JB. Drug-induced blood disorders. JAMA. 1984;252:3257\u201360.","journal-title":"JAMA"},{"key":"120_CR17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1365-2796.1996.486822000.x","volume":"239","author":"U Pedersen-Bjergaard","year":"1996","unstructured":"Pedersen-Bjergaard U, Andersen M, Hansen PB. Thrombocytopenia induced by noncytotoxic drugs in Denmark 1968\u201391. J Intern Med. 1996;239:509\u201315.","journal-title":"J Intern Med"},{"key":"120_CR18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s002280050538","volume":"54","author":"U Pedersen-Bjergaard","year":"1998","unstructured":"Pedersen-Bjergaard U, Andersen M, Hansen PB. Drug-specific characteristics of thrombocytopenia caused by non-cytotoxic drugs. Eur J Clin Pharmacol. 1998;54:701\u20136.","journal-title":"Eur J Clin Pharmacol"},{"key":"120_CR19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.hoc.2013.02.003","volume":"27","author":"BH Chong","year":"2013","unstructured":"Chong BH, Choi PY, Khachigian L, Perdomo J. Drug-induced immune thrombocytopenia. Hematol Oncol Clin North Am. 2013;27:521\u201340.","journal-title":"Hematol Oncol Clin North Am"},{"key":"120_CR20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/09537109109005508","volume":"2","author":"BH Chong","year":"1991","unstructured":"Chong BH. Drug-induced immune thrombocytopenia. Platelets. 1991;2:173\u201381.","journal-title":"Platelets"},{"key":"120_CR21","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00009","volume":"129","author":"JN George","year":"1998","unstructured":"George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, Vondracek T. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med. 1998;129:886\u201390.","journal-title":"Ann Intern Med"},{"key":"120_CR22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.hoc.2007.06.005","volume":"21","author":"GP Visentin","year":"2007","unstructured":"Visentin GP, Liu CY. Drug-induced thrombocytopenia. Hematol Oncol Clin North Am. 2007;21:685\u201396.","journal-title":"Hematol Oncol Clin North Am"},{"key":"120_CR23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.7326\/0003-4819-112-4-308","volume":"112","author":"JP Freiman","year":"1990","unstructured":"Freiman JP. Fatal quinine-induced thrombocytopenia. Ann Intern Med. 1990;112:308\u20139.","journal-title":"Ann Intern Med"},{"key":"120_CR24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1182\/asheducation-2009.1.153","volume":"2009","author":"JN George","year":"2009","unstructured":"George JN, Aster RH. Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematology Am Soc Hematol Educ Program. 2009;2009:153\u20138.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"120_CR25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2146\/ajhp090564","volume":"68","author":"R Salloum","year":"2011","unstructured":"Salloum R, Liu CY, Weise AM. Possible case of levofloxacin-induced thrombocytopenia. Am J Health Syst Pharm. 2011;68(1):43\u20136.","journal-title":"Am J Health Syst Pharm"},{"key":"120_CR26","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood-2006-01-009803","volume":"108","author":"DW Bougie","year":"2006","unstructured":"Bougie DW, Wilker PR, Aster RH. Patients with quinine-induced immune thrombocytopenia have both \u201cdrug-dependent\u201d and \u201cdrug-specific\u201d antibodies. Blood. 2006;108:922\u20137.","journal-title":"Blood"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-017-0120-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T10:40:32Z","timestamp":1568803232000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-017-0120-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["120"],"URL":"https:\/\/doi.org\/10.1186\/s40360-017-0120-2","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,7]]},"article-number":"12"}}